By DANIEL STONE As a doctor, I consider Secretary Xavier Becerra and his Department of Health and Human Services (HHS) to be allies of practitioners like me. The behemoth federal agency administers Medicare and Medicaid, the Food and Drug Administration, and an army of public health workers. The Surgeon General, symbolic leader of the nation’s…
Key industries faced a 55 percent increase in attacks over the last four years, NETSCOUT reports
In this episode, we’re joined by Dr. Barbara Levy, chief medical officer of Visana Health. We discuss the American College of Obstetricians & Gynecologists’ new clinical guidance on endometriosis. The post MedCity FemFwd: ACOG’s New Guidelines Around Endometriosis appeared first on MedCity News.
Over 25 million people were disenrolled from Medicaid and over 56 million had their coverage renewed, according to KFF’s analysis of the outcomes of the Medicaid unwinding, which nearly all states have now completed.
It’s open enrollment season for Medicare Advantage, when people currently enrolled in private managed-care plans can either sign up for a new one or switch to original Medicare through March 31. But there’s a catch: If people want to move to original Medicare and buy a supplemental Medigap insurance plan to cover some out-of-pocket costs,…
The truth is there are ways to understand our cancer risk more precisely than we do today, and there are tools to manage it. What’s missing is awareness, access, and a system built to help us use these tools before something goes wrong. The post Why We’re Still Finding Cancer Too Late appeared first on…
In response to emailed questions, the founders of MucoLife Therapeutics shared their company’s approach, which is designed to help people with COPD, cystic fibrosis, asthma, and pulmonary fibrosis. The post A Biotech Startup’s Quest to Relieve Pulmonary Mucus Obstruction for Respiratory Care appeared first on MedCity News.
Positive preliminary results for Eli Lilly’s efsitora alfa continue to build the case for this once-weekly insulin in type 2 diabetes patients. Lilly is trying to catch up to Novo Nordisk’s once weekly insulin icodec, which is commercially available in several markets around the world but is not yet approved by the FDA. The post…
Expanding the diversity of our mental health workforce is crucial, but it’s a long-term goal that won’t address the immediate needs we’re facing today. We need solutions now to bridge the gap between demand and access. The post Mental Healthcare in Underserved Populations is in Crisis and It’s Not Just a Provider Resource Problem appeared…
That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasingly argue that Americans pay too much for prescription drugs. In a recent report, the Senate Health, Education, Labor, and Pensions (HELP) Committee minority staff contended…